{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T12:34:47Z","timestamp":1791462887092,"version":"4.3.4"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T00:00:00Z","timestamp":1662422400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","award":["U54MD07597"],"award-info":[{"award-number":["U54MD07597"]}],"id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["P30AI117970"],"award-info":[{"award-number":["P30AI117970"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Racial and Ethnic Health Disparities"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1007\/s40615-022-01384-6","type":"journal-article","created":{"date-parts":[[2022,9,6]],"date-time":"2022-09-06T12:05:53Z","timestamp":1662465953000},"page":"2039-2053","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":93,"title":["The Opioid Epidemic: a Crisis Disproportionately Impacting Black Americans and Urban Communities"],"prefix":"10.1007","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9237-8286","authenticated-orcid":false,"given":"Marjorie C.","family":"Gondr\u00e9-Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomilowo","family":"Abijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy A.","family":"Gondr\u00e9-Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,9,6]]},"reference":[{"key":"1384_CR1","unstructured":"Vital statistics rapid release: provisional drug overdose death counts [Internet]. Center for Disease Control and Prevention. 2021. Available from: https:\/\/www.cdc.gov\/nchs\/nvss\/vsrr\/drug-overdose-data.htm#selection_specific_states_jurisdictions."},{"key":"1384_CR2","doi-asserted-by":"publisher","first-page":"14","DOI":"10.3390\/ijerph19148883","volume":"19","author":"AT Vo","year":"2022","unstructured":"Vo AT, Patton T, Peacock A, Larney S, Borquez A. Illicit substance use and the COVID-19 pandemic in the United States: a scoping review and characterization of research evidence in unprecedented times. Int J Environ Res Publ Health. 2022;19:14.","journal-title":"Int J Environ Res Publ Health"},{"key":"1384_CR3","doi-asserted-by":"publisher","first-page":"108094","DOI":"10.1016\/j.jsat.2020.108094","volume":"119","author":"AA Mericle","year":"2020","unstructured":"Mericle AA, Sheridan D, Howell J, Braucht GS, Karriker-Jaffe K, Polcin DL. Sheltering in place and social distancing when the services provided are housing and social support: the COVID-19 health crisis and recovery housing. J Subst Abuse Treat. 2020;119:108094.","journal-title":"J Subst Abuse Treat"},{"key":"1384_CR4","doi-asserted-by":"publisher","first-page":"653674","DOI":"10.3389\/fpsyt.2021.653674","volume":"12","author":"NM Avena","year":"2021","unstructured":"Avena NM, Simkus J, Lewandowski A, Gold MS, Potenza MN. Substance use disorders and behavioral addictions during the COVID-19 pandemic and COVID-19-related restrictions. Front Psychiatry. 2021;12:653674.","journal-title":"Front Psychiatry"},{"issue":"22","key":"1384_CR5","doi-asserted-by":"publisher","first-page":"2613","DOI":"10.1001\/jama.2008.802","volume":"300","author":"AJ Hall","year":"2008","unstructured":"Hall AJ, Logan JE, Toblin RL, Kaplan JA, Kraner JC, Bixler D, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300(22):2613\u201320.","journal-title":"JAMA"},{"issue":"2","key":"1384_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.7326\/0003-4819-152-2-201001190-00006","volume":"152","author":"KM Dunn","year":"2010","unstructured":"Dunn KM, Saunders KW, Rutter CM, Banta-Green CJ, Merrill JO, Sullivan MD, et al. Opioid prescriptions for chronic pain and overdose: a cohort study. Ann Intern Med. 2010;152(2):85\u201392.","journal-title":"Ann Intern Med"},{"issue":"6","key":"1384_CR7","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1345\/aph.1K066","volume":"41","author":"DM Hartung","year":"2007","unstructured":"Hartung DM, Middleton L, Haxby DG, Koder M, Ketchum KL, Chou R. Rates of adverse events of long-acting opioids in a state Medicaid program. Ann Pharmacother. 2007;41(6):921\u20138.","journal-title":"Ann Pharmacother"},{"issue":"1","key":"1384_CR8","first-page":"10","volume":"61","author":"(CDC) CfDCaP","year":"2012","unstructured":"(CDC) CfDCaP. CDC grand rounds: prescription drug overdoses - a U.S. epidemic. MMWR Morb Mortal Wkly Rep. 2012;61(1):10\u20133.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1384_CR9","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addbeh.2018.03.010","volume":"86","author":"P Phalen","year":"2018","unstructured":"Phalen P, Ray B, Watson DP, Huynh P, Greene MS. Fentanyl related overdose in Indianapolis: estimating trends using multilevel Bayesian models. Addict Behav. 2018;86:4\u201310.","journal-title":"Addict Behav"},{"key":"1384_CR10","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.neubiorev.2018.12.005","volume":"106","author":"SD Comer","year":"2019","unstructured":"Comer SD, Cahill CM. Fentanyl: Receptor pharmacology, abuse potential, and implications for treatment. Neurosci Biobehav Rev. 2019;106:49\u201357.","journal-title":"Neurosci Biobehav Rev"},{"key":"1384_CR11","doi-asserted-by":"crossref","unstructured":"Baldwin GT, Seth P, Noonan RK. Continued increases in overdose deaths related to synthetic opioids: implications for clinical practice. JAMA. 2021.","DOI":"10.1001\/jama.2021.1169"},{"issue":"2","key":"1384_CR12","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/add.12224","volume":"109","author":"B Fischer","year":"2014","unstructured":"Fischer B, Keates A, B\u00fchringer G, Reimer J, Rehm J. Non-medical use of prescription opioids and prescription opioid-related harms: why so markedly higher in North America compared to the rest of the world? Addiction. 2014;109(2):177\u201381.","journal-title":"Addiction"},{"issue":"26","key":"1384_CR13","doi-asserted-by":"publisher","first-page":"667","DOI":"10.15585\/mmwr.mm6526a2","volume":"65","author":"CM Jones","year":"2016","unstructured":"Jones CM, Baldwin GT, Manocchio T, White JO, Mack KA. Trends in methadone distribution for pain treatment, methadone diversion, and overdose deaths - United States, 2002\u20132014. MMWR Morb Mortal Wkly Rep. 2016;65(26):667\u201371.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"12","key":"1384_CR14","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.2105\/AJPH.2016.303483","volume":"106","author":"H Hansen","year":"2016","unstructured":"Hansen H, Netherland J. Is the prescription opioid epidemic a White problem? Am J Public Health. 2016;106(12):2127\u20139.","journal-title":"Am J Public Health"},{"key":"1384_CR15","doi-asserted-by":"publisher","first-page":"806310","DOI":"10.3389\/fpain.2021.806310","volume":"2","author":"K Allen-Watts","year":"2021","unstructured":"Allen-Watts K, Sims AM, Buchanan TL, DeJesus DJB, Quinn TL, Buford TW, et al. Sociodemographic differences in pain medication usage and healthcare provider utilization among adults with chronic low back pain. Front Pain Res (Lausanne). 2021;2:806310.","journal-title":"Front Pain Res (Lausanne)"},{"issue":"43","key":"1384_CR16","doi-asserted-by":"publisher","first-page":"967","DOI":"10.15585\/mmwr.mm6843a3","volume":"68","author":"KM Lippold","year":"2019","unstructured":"Lippold KM, Jones CM, Olsen EO, Giroir BP. Racial\/ethnic and age group differences in opioid and synthetic opioid-involved overdose deaths among adults aged \u226518 years in metropolitan areas - United States, 2015\u20132017. MMWR Morb Mortal Wkly Rep. 2019;68(43):967\u201373.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"3","key":"1384_CR17","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1111\/acem.12323","volume":"21","author":"J Perrone","year":"2014","unstructured":"Perrone J, Mycyk MB. A challenging crossroad for emergency medicine: the epidemics of pain and pain medication deaths. Acad Emerg Med. 2014;21(3):334\u20136.","journal-title":"Acad Emerg Med"},{"issue":"3","key":"1384_CR18","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1111\/acem.12328","volume":"21","author":"M Mazer-Amirshahi","year":"2014","unstructured":"Mazer-Amirshahi M, Mullins PM, Rasooly I, van den Anker J, Perrone J, Pines JM. Rising opioid prescribing in adult U.S. emergency department visits: 2001\u20132010. Acad Emerg Med. 2014;21(3):236\u201343.","journal-title":"Acad Emerg Med"},{"issue":"5","key":"1384_CR19","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1097\/EDE.0000000000000858","volume":"29","author":"MJ Alexander","year":"2018","unstructured":"Alexander MJ, Kiang MV, Barbieri M. Trends in Black and White opioid mortality in the United States, 1979\u20132015. Epidemiology. 2018;29(5):707\u201315.","journal-title":"Epidemiology"},{"key":"1384_CR20","unstructured":"Healthy People 2030. Social determinants of Health. In: U.S. Department of Health and Human Services OoDPaHP, editor. 2022."},{"key":"1384_CR21","unstructured":"World Health Organization (WHO). Social determinants of health. 2022."},{"issue":"1","key":"1384_CR22","first-page":"15","volume":"22","author":"RS Shim","year":"2012","unstructured":"Shim RS, Ye J, Baltrus P, Fry-Johnson Y, Daniels E, Rust G. Racial\/ethnic disparities, social support, and depression: examining a social determinant of mental health. Ethn Dis. 2012;22(1):15\u201320.","journal-title":"Ethn Dis"},{"key":"1384_CR23","doi-asserted-by":"crossref","unstructured":"Cotton NK, Shim RS. Social determinants of health, structural racism, and the impact on child and adolescent mental health. J Am Acad Child Adolesc Psychiatry. 2022.","DOI":"10.62414\/001c.92340"},{"key":"1384_CR24","doi-asserted-by":"crossref","unstructured":"Wang QQ, Kaelber DC, Xu R, Volkow ND. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States. Mol Psychiatry. 2020.","DOI":"10.1038\/s41380-020-00880-7"},{"issue":"5152","key":"1384_CR25","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.15585\/mmwr.mm675152e1","volume":"67","author":"L Scholl","year":"2018","unstructured":"Scholl L, Seth P, Kariisa M, Wilson N, Baldwin G. Drug and opioid-involved overdose deaths - United States, 2013\u20132017. MMWR Morb Mortal Wkly Rep. 2018;67(5152):1419\u201327.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"1384_CR26","doi-asserted-by":"publisher","first-page":"271","DOI":"10.15585\/mmwr.mm6910a4","volume":"69","author":"J O'Donnell","year":"2020","unstructured":"O\u2019Donnell J, Gladden RM, Goldberger BA, Mattson CL, Kariisa M. Notes from the field: opioid-involved overdose deaths with fentanyl or fentanyl analogs detected - 28 states and the District of Columbia, July 2016-December 2018. MMWR Morb Mortal Wkly Rep. 2020;69(10):271\u20133.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"7","key":"1384_CR27","doi-asserted-by":"publisher","first-page":"578","DOI":"10.2174\/1570159X17666191118125702","volume":"18","author":"T Abijo","year":"2020","unstructured":"Abijo T, Blum K, Gondre-Lewis MC. Neuropharmacological and neurogenetic correlates of opioid use disorder (OUD) as a function of ethnicity: relevance to precision addiction medicine. Curr Neuropharmacol. 2020;18(7):578\u201395.","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"1384_CR28","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.amepre.2020.09.008","volume":"60","author":"DJ Schober","year":"2021","unstructured":"Schober DJ, Hunt BR, Benjamins MR, Saiyed NS, Silva A, De Maio FG, et al. Homicide mortality inequities in the 30 biggest cities in the U.S. Am J Prev Med. 2021;60(3):327\u201334.","journal-title":"Am J Prev Med"},{"issue":"5","key":"1384_CR29","first-page":"518","volume":"112","author":"B Wong","year":"2020","unstructured":"Wong B, Bernstein S, Jay J, Siegel M. Differences in racial disparities in firearm homicide across cities: the role of racial residential segregation and gaps in structural disadvantage. J Natl Med Assoc. 2020;112(5):518\u201330.","journal-title":"J Natl Med Assoc"},{"issue":"1","key":"1384_CR30","doi-asserted-by":"publisher","first-page":"14","DOI":"10.15585\/mmwr.mm7101a3","volume":"71","author":"SR Kegler","year":"2022","unstructured":"Kegler SR, Stone DM, Mercy JA, Dahlberg LL. Firearm homicides and suicides in major metropolitan areas - United States, 2015\u20132016 and 2018\u20132019. MMWR Morb Mortal Wkly Rep. 2022;71(1):14\u20138.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"1384_CR31","unstructured":"DC Department of Behavioral Health."},{"issue":"12","key":"1384_CR32","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1001\/jamapsychiatry.2021.2588","volume":"78","author":"B Han","year":"2021","unstructured":"Han B, Compton WM, Jones CM, Einstein EB, Volkow ND. Methamphetamine use, methamphetamine use disorder, and associated overdose deaths among US adults. JAMA Psychiat. 2021;78(12):1329\u201342.","journal-title":"JAMA Psychiat"},{"key":"1384_CR33","doi-asserted-by":"publisher","first-page":"108384","DOI":"10.1016\/j.drugalcdep.2020.108384","volume":"218","author":"M Cano","year":"2021","unstructured":"Cano M, Huang Y. Overdose deaths involving psychostimulants with abuse potential, excluding cocaine: state-level differences and the role of opioids. Drug Alcohol Depend. 2021;218:108384.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"1384_CR34","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/add.14812","volume":"115","author":"CM Jones","year":"2020","unstructured":"Jones CM, Underwood N, Compton WM. Increases in methamphetamine use among heroin treatment admissions in the United States, 2008\u201317. Addiction. 2020;115(2):347\u201353.","journal-title":"Addiction"},{"issue":"4","key":"1384_CR35","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1007\/s40615-017-0435-0","volume":"5","author":"DM Cole","year":"2018","unstructured":"Cole DM, Thomas DM, Field K, Wool A, Lipiner T, Massenberg N, et al. The 21st Century Cures Act implications for the reduction of racial health disparities in the US criminal justice system: a public health approach. J Racial Ethn Health Disparities. 2018;5(4):885\u201393.","journal-title":"J Racial Ethn Health Disparities"},{"key":"1384_CR36","doi-asserted-by":"crossref","unstructured":"Florence C, Lui F, Rice K The economic burden of opioid use disorder and fatal opioid overdose in the United States, 2017. Drug and Alcohol Dependence (2021):218.\u00a0https:\/\/pubmed.ncbi.nlm.nih.gov\/33121867\/.","DOI":"10.1016\/j.drugalcdep.2020.108350"},{"issue":"6","key":"1384_CR37","doi-asserted-by":"publisher","first-page":"202","DOI":"10.15585\/mmwr.mm7006a4","volume":"70","author":"CL Mattson","year":"2021","unstructured":"Mattson CL, Tanz LJ, Quinn K, Kariisa M, Patel P, Davis NL. Trends and geographic patterns in drug and synthetic opioid overdose deaths - United States, 2013\u20132019. MMWR Morb Mortal Wkly Rep. 2021;70(6):202\u20137.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"9","key":"1384_CR38","doi-asserted-by":"publisher","first-page":"279","DOI":"10.15585\/mmwr.mm6709e1","volume":"67","author":"AM Vivolo-Kantor","year":"2018","unstructured":"Vivolo-Kantor AM, Seth P, Gladden RM, Mattson CL, Baldwin GT, Kite-Powell A, et al. Vital signs: trends in emergency department visits for suspected opioid overdoses - United States, July 2016-September 2017. MMWR Morb Mortal Wkly Rep. 2018;67(9):279\u201385.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"2","key":"1384_CR39","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1080\/02791072.2017.1394508","volume":"50","author":"SG Mars","year":"2018","unstructured":"Mars SG, Ondocsin J, Ciccarone D. Sold as heroin: perceptions and use of an evolving drug in Baltimore. MD J Psychoactive Drugs. 2018;50(2):167\u201376.","journal-title":"MD J Psychoactive Drugs"},{"issue":"6","key":"1384_CR40","doi-asserted-by":"publisher","first-page":"e2215425","DOI":"10.1001\/jamanetworkopen.2022.15425","volume":"5","author":"P Whitley","year":"2022","unstructured":"Whitley P, LaRue L, Fernandez SA, Passik SD, Dawson E, Jackson RD. Analysis of urine drug test results from substance use disorder treatment practices and overdose mortality rates, 2013\u20132020. JAMA Netw Open. 2022;5(6):e2215425.","journal-title":"JAMA Netw Open"},{"key":"1384_CR41","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.drugalcdep.2016.11.033","volume":"171","author":"J Suzuki","year":"2017","unstructured":"Suzuki J, El-Haddad S. A review: Fentanyl and non-pharmaceutical fentanyls. Drug Alcohol Depend. 2017;171:107\u201316.","journal-title":"Drug Alcohol Depend"},{"key":"1384_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.apha.2021.10.002","volume":"93","author":"DR Maguire","year":"2022","unstructured":"Maguire DR, Minervini V. Interactions between opioids and stimulants: behavioral pharmacology of abuse-related effects. Adv Pharmacol. 2022;93:1\u201333.","journal-title":"Adv Pharmacol"},{"key":"1384_CR43","doi-asserted-by":"crossref","unstructured":"Monnat SM, Rigg KK. The opioid crisis in rural and small town America. University of New Hampshire Carsey School of Public Policy; 2018.","DOI":"10.34051\/p\/2020.332"},{"issue":"4","key":"1384_CR44","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1080\/15332640.2017.1288189","volume":"17","author":"LE Squires","year":"2018","unstructured":"Squires LE, Palfai TP, Allensworth-Davies D, Cheng DM, Bernstein J, Kressin N, et al. Perceived discrimination, racial identity, and health behaviors among black primary-care patients who use drugs. J Ethn Subst Abuse. 2018;17(4):460\u201377.","journal-title":"J Ethn Subst Abuse"},{"key":"1384_CR45","unstructured":"Griffith C, La France B, Bacchus C, Ortega G. The effects of opioid addiction on the Black community. Intl J Coll Res Intern Med Publ Health. 2018."},{"key":"1384_CR46","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.addbeh.2018.04.022","volume":"85","author":"JS Knighton","year":"2018","unstructured":"Knighton JS, Stevens-Watkins D, Staton M, Pangburn K. Trends and mental health correlates of nonmedical opioid use among criminal justice-involved African American men. Addict Behav. 2018;85:14\u201320.","journal-title":"Addict Behav"},{"issue":"2","key":"1384_CR47","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1177\/1073110518782949","volume":"46","author":"K James","year":"2018","unstructured":"James K, Jordan A. The opioid crisis in Black communities. J Law Med Ethics. 2018;46(2):404\u201321.","journal-title":"J Law Med Ethics"},{"issue":"12","key":"1384_CR48","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.2105\/AJPH.2018.304585","volume":"108","author":"PA Muennig","year":"2018","unstructured":"Muennig PA, Reynolds M, Fink DS, Zafari Z, Geronimus AT. America\u2019s declining well-being, health, and life expectancy: not just a White problem. Am J Publ Health. 2018;108(12):1626\u201331.","journal-title":"Am J Publ Health"},{"issue":"49","key":"1384_CR49","doi-asserted-by":"publisher","first-page":"15078","DOI":"10.1073\/pnas.1518393112","volume":"112","author":"A Case","year":"2015","unstructured":"Case A, Deaton A. Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st century. Proc Natl Acad Sci U S A. 2015;112(49):15078\u201383.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1384_CR50","first-page":"2","volume":"10","author":"C Griffith","year":"2018","unstructured":"Griffith C, La France B, Bacchus C, Ortega G. The effects of opioid addiction on the Black community. Int J Coll Res Intern Med Publ Health. 2018;10:2.","journal-title":"Int J Coll Res Intern Med Publ Health"},{"key":"1384_CR51","doi-asserted-by":"publisher","first-page":"4","DOI":"10.3390\/biomedicines10040870","volume":"10","author":"MC Gondr\u00e9-Lewis","year":"2022","unstructured":"Gondr\u00e9-Lewis MC, Elman I, Alim T, Chapman E, Settles-Reaves B, Galvao C, et al. Frequency of the dopamine receptor D3 (rs6280) vs. opioid receptor \u00b51 (rs1799971) polymorphic risk alleles in patients with opioid use disorder: a preponderance of dopaminergic mechanisms? Biomedicines. 2022;10:4.","journal-title":"Biomedicines"},{"key":"1384_CR52","doi-asserted-by":"crossref","unstructured":"Limgala RP, Furtak V, Ivanova MM, Changsila E, Wilks F, Fidelia-Lambert MN, Goker-Alpan O, Gondr\u00e9-Lewis MC. Selective screening for lysosomal storage disorders in a large cohort of minorities of African descent shows high prevalence rates and novel variants. JIMD Rep. 2021;59(1):60\u201368.","DOI":"10.1002\/jmd2.12201"},{"key":"1384_CR53","doi-asserted-by":"crossref","unstructured":"Abijo T, Blum K, Gondr\u00e9-Lewis MC. Neuropharmacological and neurogenetic correlates of opioid use disorder (OUD) as a function of ethnicity: relevance to precision addiction medicine. Curr Neuropharmacol. 2019.","DOI":"10.2174\/1570159X17666191118125702"},{"issue":"7","key":"1384_CR54","doi-asserted-by":"publisher","first-page":"5526","DOI":"10.1007\/s12035-017-0758-1","volume":"55","author":"K Blum","year":"2018","unstructured":"Blum K, Badgaiyan RD, Dunston GM, Baron D, Modestino EJ, McLaughlin T, et al. The DRD2 Taq1A A1 allele may magnify the risk of Alzheimer\u2019s in aging African-Americans. Mol Neurobiol. 2018;55(7):5526\u201336.","journal-title":"Mol Neurobiol"},{"issue":"10","key":"1384_CR55","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.biopsych.2017.12.016","volume":"84","author":"Z Cheng","year":"2018","unstructured":"Cheng Z, Zhou H, Sherva R, Farrer LA, Kranzler HR, Gelernter J. Genome-wide association study identifies a regulatory variant of RGMA associated with opioid dependence in European Americans. Biol Psychiatry. 2018;84(10):762\u201370.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"1384_CR56","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.biopsych.2013.08.034","volume":"76","author":"J Gelernter","year":"2014","unstructured":"Gelernter J, Kranzler HR, Sherva R, Koesterer R, Almasy L, Zhao H, et al. Genome-wide association study of opioid dependence: multiple associations mapped to calcium and potassium pathways. Biol Psychiatry. 2014;76(1):66\u201374.","journal-title":"Biol Psychiatry"},{"key":"1384_CR57","first-page":"8","volume":"6","author":"EB Ettienne","year":"2017","unstructured":"Ettienne EB, Chapman E, Maneno M, Ofoegbu A, Wilson B, Settles-Reaves B, et al. Pharmacogenomics-guided policy in opioid use disorder (OUD) management: an ethnically-diverse case-based approach. Addict Behav Rep. 2017;6:8\u201314.","journal-title":"Addict Behav Rep"},{"key":"1384_CR58","unstructured":"Chapman E, Ettienne E, Clarke M, Dunston G. Wide pharmacogenetic variations in dosing of buprenorphine in the treatment of opioid addiction in African Americans\u00a02nd International Conference on Addiction Medicine and Reward Deficiency Syndrome; Baltimore, MD2017."},{"key":"1384_CR59","doi-asserted-by":"publisher","first-page":"13","DOI":"10.3390\/ijerph19137561","volume":"19","author":"MS Ruiz","year":"2022","unstructured":"Ruiz MS, Williams A, O\u2019Rourke A, MacIntosh E, Mon\u00e9 S, Clay C. The impact of housing insecurity on access to care and services among people who use drugs in Washington, DC. Int J Environ Res Publ Health. 2022;19:13.","journal-title":"Int J Environ Res Publ Health"}],"container-title":["Journal of Racial and Ethnic Health Disparities"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-022-01384-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40615-022-01384-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40615-022-01384-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T09:55:44Z","timestamp":1744192544000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40615-022-01384-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,6]]},"references-count":59,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["1384"],"URL":"https:\/\/doi.org\/10.1007\/s40615-022-01384-6","relation":{},"ISSN":["2197-3792","2196-8837"],"issn-type":[{"value":"2197-3792","type":"print"},{"value":"2196-8837","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,6]]},"assertion":[{"value":"27 May 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 September 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study uses publicly available data and thus does not require Ethics Committee review.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}